Target intelligence / Profile preview

SPOUT domain-containing methyltransferase 1 (SPOUT1)

Target
SPOUT1
Molecular classification
Enzyme, RNA methyltransferase, SPOUT methyltransferase superfamily
01

Overview

SPOUT domain-containing methyltransferase 1 (SPOUT1), also known as CENP-32 or C9orf114, is a SAM-dependent RNA methyltransferase belonging to the SPOUT superfamily, characterized by a deeply knotted trefoil fold and a specific OB-fold insertion involved in nucleic acid recognition[1][2]. It acts primarily to catalyze N3 methylation of uridine residues in 28S rRNA, using S-adenosyl-L-methionine (SAM) as the methyl group donor[1]. SPOUT1 is crucial for the assembly of the mitotic spindle and proper chromosome segregation, mediated by its methyltransferase activity and its role in tethering centrosomes to spindle poles in dividing cells[1]. Bi-allelic variants of SPOUT1 are associated with neurodevelopmental disorders and defects in mitosis in model organisms, indicating its importance for cell division and neural development[1]. No currently approved drugs directly target this enzyme, and there are no well-established clinical biomarkers. As a member of the SPOUT methyltransferase family, it is structurally and functionally distinct from other methyltransferases, with the SPOUT domain contributing to both catalysis and nucleic acid substrate recognition[1][2].

Other names
28S rRNA (uridine-N(3))-methyltransferaseC9orf114CENP-32HSPC109Centromere protein 32Kinetochore-associated proteinMethyltransferase C9orf114Ribosomal RNA methyltransferase SPOUT1putative methyltransferase C9orf114NEDGSB
02

Mechanism of action

S-adenosyl-L-methionine (SAM)-dependent methyl group transfer to rRNA (N3 methylation of uridine in 28S rRNA)

03

Biological functions

rRNA methylationMitotic spindle assemblyChromosome segregationCentrosome tethering
04

Disease associations

Neurodevelopmental disorder (human genetic variants affect neurodevelopment and mitosis)Potential role in cancer or chromosomal instability (due to effects on spindle and chromosome segregation)
05

Safety considerations

Genetic variants may confer neurodevelopmental disorders and mitotic errors

Beyond the preview

Go deeper on SPOUT domain-containing methyltransferase 1 (SPOUT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPOUT domain-containing methyltransferase 1 (SPOUT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call